VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Thursday, January 8, 2026
Stock Comparison
Cochlear Limited vs West Pharmaceutical Services, Inc.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Cochlear Limited
COH · ASX
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Cochlear Limited's moat claims, evidence, and risks.
View COH analysisWest Pharmaceutical Services, Inc.
WST · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into West Pharmaceutical Services, Inc.'s moat claims, evidence, and risks.
View WST analysisComparison highlights
- Moat score gap: West Pharmaceutical Services, Inc. leads (85 / 100 vs 81 / 100 for Cochlear Limited).
- Segment focus: Cochlear Limited has 3 segments (62.4% in Cochlear Implants); West Pharmaceutical Services, Inc. has 2 segments (80.7% in Proprietary Products).
- Primary market structure: Oligopoly vs Quasi-Monopoly. Pricing power: Moderate vs Moderate.
- Moat breadth: Cochlear Limited has 8 moat types across 3 domains; West Pharmaceutical Services, Inc. has 5 across 3.
Primary market context
Cochlear Limited
Cochlear Implants
Cochlear implant systems (internal implant + external sound processors) for severe-to-profound hearing loss
Global
Hospitals/ENT clinics and audiology programs (providers) serving implant candidates/recipients; reimbursed by public/private payers
Medical device OEM / platform owner (implant + processor + fitting software + clinical support)
62.4%
West Pharmaceutical Services, Inc.
Proprietary Products
Injectable primary packaging components and containment/delivery systems (elastomeric stoppers, seals, plungers, syringe/cartridge components; related services)
Global
Biologic, generic, and pharmaceutical drug manufacturers
Primary packaging and delivery component supplier
80.7%
Side-by-side metrics
Moat coverage
Shared moat types
Cochlear Limited strengths
West Pharmaceutical Services, Inc. strengths
Segment mix
Cochlear Limited segments
Full profile >Cochlear Implants
Oligopoly
Services
Monopoly
Acoustics
Oligopoly
West Pharmaceutical Services, Inc. segments
Full profile >Proprietary Products
Quasi-Monopoly
Contract-Manufactured Products
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listLooking for expansion-stage stocks?
Proven models entering the expansion stage with unit economics that work.
View expansion-stage stocksCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.